NFE2L2 and systemic lupus erythematosus: The other compounds which have been shown to activate Nrf2, such as epigallocatechin-3-gallate [42] or hemin [43], have also suppressed renal disease in spontaneous lupus mice, such as NZB/W F1 or MRL/lpr mice.